1 / 135

Lesson 5 : Medical Nutrition Therapy

Lesson 5 : Medical Nutrition Therapy. Types of DM. Type 1(5-10%) Type 2 (90-95%) Gestational “Other Specific Types” from specific genetic syndromes surgery drugs Malnutrition (old term) infections other illnesses Impaired glucose tolerance (pre-diabetes). Types of DM.

oshin
Download Presentation

Lesson 5 : Medical Nutrition Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lesson 5 : Medical Nutrition Therapy

  2. Types of DM • Type 1(5-10%) • Type 2 (90-95%) • Gestational • “Other Specific Types” from • specific genetic syndromes • surgery • drugs • Malnutrition (old term) • infections • other illnesses • Impaired glucose tolerance (pre-diabetes)

  3. Types of DM * growing incidence in adolescents

  4. ADA Terminology Update

  5. Diagnostic Criteria FPG = Fasting Plasma Glucose RPG = Random Plasma Glucose OGTT = Oral Glucose Tolerance Test

  6. Epidemiology • Epidemic increase in type 2 diabetes • currently 90 % of all forms of diabetes • Predictions • 6-8 % of the world population will suffer from diabetes in the next quarter of a century • 300 million people worlwide

  7. 215 250 160 200 Million people 100 150 100 50 0 1995 2000 2010 DM2 Doubling of the prevalence of DM2 to 215 million in the next 15 years 50% not yet diagnosed in Europe & North America! Diabetes 1994-2010: Global Estimates and Projections Jiwa F. Statistical Bulletin. Jan-Mar 1997;2-8

  8. Diabetes Number in Millions Year

  9. Diabetes: A Worldwide Epidemic • The Rise in Diabetes: Why? • Increasing longevity. • Change in demographics and genetic predispositions: the greatest growth of patients will be in Asia, where it is predicted that by 2010, over 60% of the patients suffering from diabetes will live in this region of the world. • Rising urbanization and change in lifestyle. • Increase in obesity: over 60% of the adult population in the United States (and Australia) are either overweight or obese.

  10. Diabetes: A Worldwide Epidemic Percent of Individuals Considered Obese in a Given Country 2% 15% 25% 50% 70% Japan Samoa Europe Jordan US

  11. Diabetes, Obesity & Adolescence • In developing nations, more than 70% of the childhood population presenting with diabetes suffers from type 2 disease. • In the United States, type 2 diabetes is preferentially affecting the obese Hispanic and African-American population. • In the United States, adolescent clinics describe 1/3 to 1/2 of their new diabetics as type 2 patients (Henry Ford Health Clinic, Detroit). • The incidence of diabetes in children has increased 10 fold when compared with a decade ago.

  12. Ratio 2.5 Ratio 2.2 Ratio 2.1 35 32.0 26.9 26.9 30 25 Control 15.5 20 (numberof deaths per 1000 patient years) 12.5 Diabetes 10.8 15 10 Mortality 5 0 10,025 61 6629 279 631 24 (No of patients) Helsinki Policemen Study Paris Prospective Study Whitehall Study Mortality in diabetes patients double that compared to non-diabetics Balkau Lancet 1997; 350:1680

  13. Causes of Death Among People With Diabetes Cause % of Deaths 40 15 13 13 10 4 5 Ischemic heart disease Other heart disease Diabetes (acute complications) Cancer Cerebrovascular disease Pneumonia/influenza All other causes Geiss LS et al. In: Diabetes in America. 2nd ed.1995:233-257.

  14. Complications of Diabetes • Macrovascular • coronary artery disease (MI) • cerebrovascular disease (Stroke) • peripheral vascular disease • Microvascular • retinopathy • nephropathy • neuropathy

  15. Diabetes complications • Retinopathy (blindness?) • Nephropathy (kidney problems) • Feet ulceration and/or amputations • Hypertension • Hyperlipidemia (cholesterol?) • Gestational diabetes (during pregnancy) • Diabetes and HIV • Erectile Dysfunction

  16. "therapies for weight reduction" 2

  17. Diabetes complications

  18. HbA1c – relationship with CV risk Glycaemia increase Associated risk increase 1%increase in HbA1c 43%increase in peripheral vascular diseasep<0.0001 21%increase in diabetes-related deathsp<0.0001 14%increase in myocardial infarctionp<0.0001 Stratton IM et al. BMJ 2000; 321: 405–12.

  19. Why Treat Diabetes? • DCCT • Diabetes Control and Complications Trial • 10-year study in 1441 patients with Type 1 DM • Kumamoto Study • 6-year study in 110 Japanese patients with Type 2 DM • UKPDS • United Kingdom Prospective Diabetes Study • 20-year study of 5102 newly diagnosed Type 2 DM

  20. The burden of type 2 diabetes can be reduced The UKPDS showed that, when glucose levels are above normal, any reduction in HbA1c is beneficial = 25% reduction microvascular complications 0.9% reduction in HbA1c UKPDS 33. Lancet 1998;352:837–853.

  21. Preventative MeasuresDCCT • Intensive control of blood glucose reduced risk of diabetic complications • 76% reduction retinopathy onset • 54% reduction retinopathy progression • 54% reduction nephropathy • 60% reduction neuropathy • 2-3x greater incidence of severe hypoglycemia DCCT Research Group N Engl J Med. 1993;329: 977-986.

  22. UKPDS Key Messages • To reduce the complications of diabetes, it is necessary to control: • blood glucose and HbA1c levels • blood pressure • Epidemiologic analyses showed that for every percentage • point reduction in HbA1c, there was a • 35% reduction in microvascular complications • 25% reduction in diabetes-related deaths • 18% reduction in MI American Diabetes Association. Diabetes Care. 1999;22(suppl 1):S27-S31. UKPDS Group. Lancet. 1998;352:854-865. UKPDS Group. BMJ. 1998;317:703-713. Nathan D. Lancet. 1998;352:832-833. ©1998 PPS

  23. It Works…….at least for some things 1 The DCCT Group. N Engl. J Med 1993. 2 Ohkubo Y, etl. al. Diab Res Clin Pract 1995. 3 UKPDS Group. Diabetes Care 1998.

  24. Goals of Treatment • Alleviate symptoms • Prevent complications • Prevent progression of current complications • Improve quality of life • Alleviate symptoms • Prevent complications • Prevent progression of current complications • Improve quality of life

  25. ADA Goals of Treatment (cont.)

  26. Other Glycemic Measures • A1C • measure of how much hemoglobin has been glycosylated • represents an “average glucose” over the last 3 months • Fructosamine • measure of proteins that are glycosylated • represents an “average glucose” over 2-4 weeks

  27. Diabetic control • Normal HBA1C 3.5 – 6.5% • Targets

  28. Collaborative Management • Nutritional Therapy • Activity • Monitoring of Blood Glucose • Medication - Insulin or Oral Agents • Education

  29. Nutritional Therapy • Cornerstone of care for Diabetic • No one “diabetic” or “ADA” diet • Use individualized approach • Consider financial status and cultural and ethnic influences • Priority placed on amount of CHO, not source of the CHO

  30. Nutrition • Nutrition Therapy – The Most Fundamental Component of the Diabetes Treatment Plan • Goals: • Near Normal Glucose Levels • Normal Blood Pressure • Normal Serum Lipid Levels • Reasonable Body Weight • Promotion of Overall Health

  31. Nutrition TherapyDiet Teaching • Goal - independence; effective self-management. • Include Family. • Follow prescribed plan; accurate portions • Never skip meals • Concern - Alcohol • Concern - Dietetic Foods

  32. Nutrient Components • Protein* • Fat* • CHO* • Sucrose and Fructose • Nutritive Sweeteners • Fat Replacements* • Vitamins and Minerals • Alcohol Intake*

  33. Increase in energy intake possible Diet and Insulin nec. to control BS Equal distribution of CHO through meals for insulin activity Consistency in daily intake - control BS Reduction of energy intake for obese Diet alone may control blood glucose Equal distribution of CHO desirable, not essential;low fat desirable Consistency in daily intake - control wt. Nutrition Goals forType 1 ****** Type 2

  34. Timing of meals - crucial Snacks - frequently necessary Additional food for exercise - CHO 20 g/h for moderate physical activity Timing of meals not essential Snacks - not recommended Additional food for exercise if on sulfonylurea or insulin Nutritional Goals (con’t)Type I ****Type 2

  35. Dietary Management of Diabetes • Maintain as near-normal blood glucose levels as possible by balancing food, insulin and exercise • Achieve recommended serum blood lipid levels • Provide energy intake to maintain or attain healthy weight • Prevent and treat acute and long-term diabetes-related complications • Enhance over all health

  36. Dietary Intake in US(NHANES III) • Mean daily intake • 2095 Total kcal • 34% Fat • 15% Protein • 50% CHO • 2% Alcohol

  37. Macronutrient Composition of Various Diets

  38. Major Dietary Guidance Tools • Recommended Dietary Allowances • 1989 10th Edition currently being revised • Dietary Reference Intakes (DRIs) • RDAs ,Tolerable Upper Intake Level (UL), Estimated Average Requirement (EAR) and Adequate Intake (AI) • Yates et al, Jour Am Diet Assoc. 1998:98:699-706 • The Food Guide Pyramid • Human Nutrition Information Service, Home and Garden Bulletin Number 252, Hyattsville, MD:USDA, 1992 • 1995 US Dietary Guidelines • USDA and USDHHS, Nutrition and your health: Dietary guidelines for Americans, 4th edition, 1995; Home and Garden Bulletin No. 232,Washington, DC:USDA, 1995

  39. Type 1 Diabetes Mellitus

  40. Nutrition Goals for Type 1 • Consider intensive insulin therapy to allow flexibility in meal patterns • Integrate insulin therapy with usual food intake • Develop an eating pattern based on person’s usual food intake • Monitor blood glucose levels • Ref: Manual of Clinical Nutrition, 2000

  41. Meal Planning • Term “ADA Diet” is obsolete • Avoid the terms • no concentrated sweets • low sugar diet • liberal diabetic diet

  42. Medical Nutrition Therapy • Meal plans should be individualized • based on • nutrition assessment • medical history • psycho-social assessment • treatment goals

  43. Carbohydrate Consistency • CHO intake and distribution should be comparable from one day to the next. • CHO content of meals within the same day can vary.

  44. Type of Carbohydrate • The total amount of CHO eaten is more important than the source or type. • Clinical studies do not justify the longtime belief that sucrose must be restricted.

  45. Glycemic Index • Compares various CHO foods and ranks them according to effect on BG. • Limitations: • compared 50 g CHO from each source, actual portion sizes weren’t necessarily comparable. • looked at BG response when each item was eaten alone, on an empty stomach. Mixed meals would produce a different effect. • People may unnecessarily restrict healthful foods.

  46. Sugars and Sweeteners • Sugar, honey, syrup...1 Tbs. =15g CHO • Fructose slightly lower post-prandial response. • Sugar alcohol is a form of carbohydrate, but labels can technically state “sugar free”. • FDA approves 4 sugar substitutes which have no CHO: • aspartame, saccharin, acesulfame-K, sucralose

  47. Macronutrient Composition • No absolute percentages • CHO and MUFA should be 60-70% kcals • SFA < 10% kcals • Protein intakes of 15-20% kcals

  48. Sample energy distribution • 50-60 % CHO • 15-20 % Protein • 20-30 % Fat

  49. Protein Intake • Small to medium portion of protein once daily • 12-20% of daily calories • From both animal and vegetable sources • Vegetable source less nephrotoxic than animal protein • 3-5oz (100-150g) of meat, fish or poultry daily • Patient with nephropathy should limit to less than 12% daily

  50. Fat Intake • <35% of total calories • Saturated fat <10% of total calories • Polyunsaturated fats 10% of total calories • Cholesterol consumption < 300 mg • Moderate increase in monounsaturated fats such as canola oil and olive oil (up to 20% of total calories)

More Related